The vaginal antifungals market sales is expected to develop at a 4.5% compound annual growth rate (CAGR) throughout the forecast period, reaching a worth of US$ 1.09 billion in 2022. According to a recent report by Future Market Insights, Polygenes is expected to hold the top rank with a about 49.0% share in the global …